← Leaderboards
Ming Xu
University Of Connecticut Sch Of Med/Dnt
$6,235,062
Attributed
$8,162,616
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.3M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,488,648 · 7
By mechanism
R01$6,943,298 · 3
U54$5,326,032 · 1
R21$891,318 · 2
R03$328,000 · 1
Top collaborators
- Yanjiao Zhou7 shared
- Laura Haynes2 shared
- Ronny Korstanje2 shared
- George A Kuchel2 shared
- Paul Robson2 shared
- Nadia A Rosenthal2 shared
- Phillip Paul Smith2 shared
Most similar at University Of Connecticut Sch Of Med/Dnt
Same institution · by research overlap
- Rachel Cohn$151,728
- Jenna Bartley$2,410,090
- Phillip Paul Smith$3,381,507
Others in their field
Other Emerging Leaders on “Aging”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$64,693,871
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$25,556,733
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$25,272,240
- Abraham Aizer Brody · New York University School Of Medicine$23,963,022
Research focus
AgingCellsTissuesAge RelatedSenescenceCell AgingMouse ModelTransgenic MiceIn VivoFoundationsFunctional DisorderAffectBiological AgingPlayObesityFutureChronic DiseaseStressInsulin ResistanceLongevityCell TypeMetabolic DysfunctionRisk FactorsAutomobile Driving
Grant awards (24)
Targeting p21-Highly Expressing Cells to Increase Lifespan and Healthspan in Old Age$450,817
R01 · FY2025 · AG · contact PI
Reciprocal Modulation of the Microbiome and Cellular Senescence in Metabolic Dysfunction$516,029
R01 · FY2024 · AG
Targeting p21-Highly Expressing Cells to Increase Lifespan and Healthspan in Old Age$479,636
R01 · FY2024 · AG · contact PI
Targeting p21-positive Senescent Cells in vivo for Alleviating Metabolic and Physical Dysfunction$415,758
R01 · FY2024 · AG · contact PI
Reciprocal Modulation of the Microbiome and Cellular Senescence in Metabolic Dysfunction$73,114
R01 · FY2024 · AG
Reciprocal Modulation of the Microbiome and Cellular Senescence in Metabolic Dysfunction$42,531
R01 · FY2024 · AG
The Jackson Laboratory Senescence Tissue Mapping Center (JAX-Sen TMC)$2,839,947
U54 · FY2023 · AG
Reciprocal Modulation of the Microbiome and Cellular Senescence in Metabolic Dysfunction$530,524
R01 · FY2023 · AG
Targeting p21-Highly Expressing Cells to Increase Lifespan and Healthspan in Old Age$486,637
R01 · FY2023 · AG · contact PI
Targeting p21-positive Senescent Cells in vivo for Alleviating Metabolic and Physical Dysfunction$425,844
R01 · FY2023 · AG · contact PI
The Jackson Laboratory Senescence Tissue Mapping Center (JAX-Sen TMC)$2,486,085
U54 · FY2022 · AG
Reciprocal Modulation of the Microbiome and Cellular Senescence in Metabolic Dysfunction$535,801
R01 · FY2022 · AG
Targeting p21-Highly Expressing Cells to Increase Lifespan and Healthspan in Old Age$497,766
R01 · FY2022 · AG · contact PI
Targeting p21-positive Senescent Cells in vivo for Alleviating Metabolic and Physical Dysfunction$448,875
R01 · FY2022 · AG · contact PI
Can Senolytics Improve the Aged Response to Viral Infection$205,000
R21 · FY2022 · AG
Targeting P21-Highly-Expressing Senescent Cells In Vivo for Improving Cognitive Function in the Alzheimers Diseases$164,000
R03 · FY2022 · AG · contact PI
Reciprocal Modulation of the Microbiome and Cellular Senescence in Metabolic Dysfunction$539,378
R01 · FY2021 · AG
Targeting p21-positive Senescent Cells in vivo for Alleviating Metabolic and Physical Dysfunction$466,525
R01 · FY2021 · AG · contact PI
Can Senolytics Improve the Aged Response to Viral Infection$246,000
R21 · FY2021 · AG
Targeting P21-Highly-Expressing Senescent Cells In Vivo for Improving Cognitive Function in the Alzheimers Diseases$164,000
R03 · FY2021 · AG · contact PI
Reciprocal Modulation of the Microbiome and Cellular Senescence in Metabolic Dysfunction$579,640
R01 · FY2020 · AG
Targeting p21-positive Senescent Cells in vivo for Alleviating Metabolic and Physical Dysfunction$454,423
R01 · FY2020 · AG · contact PI
Role of Senolytics in Lower Urinary Tract Aging and Voiding Disorders$205,000
R21 · FY2020 · AG
Role of Senolytics in Lower Urinary Tract Aging and Voiding Disorders$235,318
R21 · FY2019 · AG